Rennova Health, Inc. (RNVA)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
Feb 21, 2025, 3:00 PM EST
Rennova Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 18.69 | 13.04 | 3.22 | 7.2 | 16 | Upgrade
|
| Revenue Growth (YoY) | 43.34% | 304.36% | -55.22% | -55.01% | 10.00% | Upgrade
|
| Cost of Revenue | 7.57 | 6.77 | 5.29 | 11.78 | 14.76 | Upgrade
|
| Gross Profit | 11.11 | 6.27 | -2.07 | -4.58 | 1.24 | Upgrade
|
| Selling, General & Admin | 9.44 | 7.22 | 7.51 | 11.66 | 15.9 | Upgrade
|
| Operating Expenses | 9.75 | 7.69 | 8.15 | 12.36 | 16.69 | Upgrade
|
| Operating Income | 1.37 | -1.42 | -10.22 | -16.95 | -15.45 | Upgrade
|
| Interest Expense | -1.45 | -2.26 | -3.19 | -9.84 | -21.73 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.85 | -0.17 | 1.25 | -2.64 | -2.51 | Upgrade
|
| EBT Excluding Unusual Items | 0.76 | -3.84 | -12.16 | -29.43 | -39.69 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.25 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.82 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.27 | -0.01 | - | Upgrade
|
| Asset Writedown | - | - | -2.3 | -0.25 | - | Upgrade
|
| Legal Settlements | -0.76 | -0.13 | 3.25 | 0.67 | - | Upgrade
|
| Other Unusual Items | 0.5 | 0.93 | 6.39 | 10.06 | -6.64 | Upgrade
|
| Pretax Income | -0.31 | -3.04 | -5.09 | -18.95 | -46.58 | Upgrade
|
| Income Tax Expense | 0.24 | 0.31 | 0.18 | -1.31 | - | Upgrade
|
| Earnings From Continuing Operations | -0.55 | -3.35 | -5.27 | -17.64 | -46.58 | Upgrade
|
| Earnings From Discontinued Operations | -7.2 | 0.06 | 10.88 | -0.7 | -1.45 | Upgrade
|
| Net Income to Company | -7.75 | -3.29 | 5.61 | -18.34 | -48.03 | Upgrade
|
| Minority Interest in Earnings | 0.02 | - | - | - | - | Upgrade
|
| Net Income | -7.73 | -3.29 | 5.61 | -18.34 | -48.03 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 330.88 | 506.48 | 263.25 | 123.86 | Upgrade
|
| Net Income to Common | -7.73 | -334.17 | -500.87 | -281.59 | -171.9 | Upgrade
|
| Shares Outstanding (Basic) | 32,826 | 9,992 | 1 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 32,826 | 9,992 | 1 | - | - | Upgrade
|
| Shares Change (YoY) | 228.51% | 1822047.62% | - | - | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.03 | -913.37 | - | - | Upgrade
|
| EPS (Diluted) | -0.00 | -0.03 | -913.37 | - | - | Upgrade
|
| Free Cash Flow | 3.04 | -0.25 | -8.91 | -17.3 | -13.53 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.00 | -16.25 | - | - | Upgrade
|
| Gross Margin | 59.46% | 48.08% | -64.16% | -63.66% | 7.77% | Upgrade
|
| Operating Margin | 7.31% | -10.88% | -317.00% | -235.35% | -96.54% | Upgrade
|
| Profit Margin | -41.36% | -2563.40% | -15536.23% | -3910.97% | -1074.12% | Upgrade
|
| Free Cash Flow Margin | 16.25% | -1.95% | -276.46% | -240.26% | -84.54% | Upgrade
|
| EBITDA | 1.68 | -0.95 | -9.58 | -16.24 | -14.65 | Upgrade
|
| EBITDA Margin | 8.97% | -7.28% | -297.04% | -225.61% | -91.57% | Upgrade
|
| D&A For EBITDA | 0.31 | 0.47 | 0.64 | 0.7 | 0.8 | Upgrade
|
| EBIT | 1.37 | -1.42 | -10.22 | -16.95 | -15.45 | Upgrade
|
| EBIT Margin | 7.31% | -10.88% | - | -235.35% | -96.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.